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wOne  in  ten  babies  worldwide  are  born  preterm  every  year;
over 90%  of  these  are  born  in  low  and  middle-income  coun-
tries such  as  Brazil.1 Improvements  in  neonatal  intensive
care and  increased  survival  of  preterm  infants  has  led  to  an
increasing focus  on  the  long-term  impacts  of  preterm  birth,
specifically with  respect  to  metabolic  outcomes  such  as  bone
mineral  density  (BMD)  and  timing  and  extent  of  catch-up
growth.
Metabolic bone disease of prematurity
Preterm  infants  are  particularly  susceptible  to  metabolic
bone disease  for  two  key  reasons:  Firstly,  80%  of  fetal  bone
mineral accumulation  occurs  during  the  last  trimester  of
pregnancy, with  a  surge  in  placental  transfer  of  calcium,
magnesium, and  phosphorus  to  the  neonate.2 A  preterm
infant ex-utero  must  accrete  bone  mineral  during  this
period without  the  support  of  the  regulatory  placental
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ificantly lower  bone  mineral  content  (BMC)  than  those
orn at  term.  Secondly,  ex-utero  living  conditions  make  it
ore difficult  for  infants  to  move  and  stress  their  bones  as
hey would  have  done  in-utero.3 As  well  as  mineral  insuf-
ciency, lower  BMD  is  also  a  consequence  of  other  factors
uch as  medication  (e.g.  steroids,  diuretics,  etc.),  respira-
ory compromise,4 and  infection,5 which  may  damage  bone
rabeculae. Although  metabolic  bone  disease  of  prematurity
s often  asymptomatic  and  described  as  self-limiting,6 con-
ern remains  that  under-mineralization  during  such  a  critical
eriod  could  increase  the  risk  of  childhood  fracture.  Perhaps
ore importantly,  it  may  result  in  reduced  peak  bone  mass,7
hich  is  a  key  predictor  for  risk  of  osteoporosis  in  adulthood.
mpact of preterm birth on later metabolic
one  outcomes
n  this  issue  of  Jornal  de  Pediatria,  Quintal  et  al.8 have
onducted a  comprehensive  longitudinal  study,  examining
one mineralization  and  body  composition  using  dual  X-ray
bsorptiometry (DXA)  in  14  preterm  infants  over  the  first  six
ostnatal  months,  and  compared  them  to  infants  born  full
erm. This  is  important,  as  previous  research  studies  have
roduced conflicting  data  on  the  effect  of  prematurity  on
ater BMD.  Consistent  with  data  from  this  study,  previous
tudies in  preterm  infants  have  shown  a  lower  bone  mass,9
er Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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MD,7 and  BMC4 at  the  corrected  age  of  term,  as  well  as  a
ower weight  and  ponderal  index.7 Several  studies,  however,
ave failed  to  demonstrate  an  association  between  preterm
irth and  later  bone  strength,5,10,11 whilst  others  have  shown
reater BMC  and  BMD  in  term  children  compared  to  preterm,
t follow-up.4,12 A  possible  explanation  for  the  variation  in
tudy results  may  be  in  the  timing  of  follow-up  as  catch-
p in  bone  mineralization  may  occur  throughout  childhood
nd adolescence.13 Of  note,  in  Quintal  et  al.’s  study,8 catch-
p bone  mineralization  appears  to  have  occurred  in  early
nfancy; thus,  data  from  preterm  and  full-term  infants  were
omparable  by  6 months  of  age.  This  may  be  attributable  to
he persisting  benefits  of  growth  factors  present  in  breast
ilk, as  Quintal  et  al.’s  cohort  were  all  breastfed,  compared
o much  of  the  published  data  from  formula  fed  babies.  Con-
inued follow  up  of  this  cohort  with  further  DXA  scans  in  later
hildhood and  adulthood  would  provide  additional  insights
nto their  peak  bone  mass.
The  exact  influence  of  birth  weight  on  later  BMD  remains
nclear. Some  studies  have  found  that,  although  preterm-
orn infants  were  lighter  during  childhood  than  their  term
ounterparts, their  BMD  was  appropriate  for  size.  Adults
ho were  born  preterm  remain  on  average  slightly  shorter
han their  term-born  peers.  As  some  studies  may  not  have
ade appropriate  adjustments  for  current  size,  it  may  be
ifficult to  determine  whether  BMD  is  appropriate  or  not.
here is  also  evidence  that  very  low  birth  weight  (VLBW)
nfants, whether  preterm  or  not,  attain  a  sub-optimal  peak
one mass  in  part  due  to  their  small  size,  but  also  due  to
heir subnormal  skeletal  mineralisation.5 The  Hertfordshire
ohort study  (which  formed  the  basis  for  several  of  Barker’s
tudies) showed  that  birth  weight  was  independently  asso-
iated with  bone  density  at  60-75  years  of  age.  Although
nother study  found  no  association  with  preterm  birth  and
eak bone  mass,14 an  effect  of  being  small  for  gestational
ge was  apparent,  suggesting  that  a  proportion  of  later  bone
ass  is  determined  by  in  utero  events,  such  as  fetal  growth.
he challenges of optimizing neonatal
utrition
he  use  of  fortified  breast  milk  in  this  study  and  exclu-
ive breastfeeding  post-discharge  is  commendable.  Maternal
reast milk  is  associated  with  a  range  of  benefits  both  in  the
hort-term (e.g.  reduction  in  the  incidence  of  necrotizing
nterocolitis) and  long-term  (e.g.  improved  cognitive  out-
ome.) A  study  by  Fewtrell  at  al.15 showed  that  the  variable
ith the  greatest  effect  on  adult  BMD  was  the  proportion  of
reast milk  intake.  Given  that  breast  milk  has  a  much  lower
ineral content  than  formula,  and  requires  fortification  to
eet nutrient  requirements,  the  data  of  Fewtrell  et  al.
uggests a  possible  beneficial  role  for  non-nutrient  compo-
ents such  as  growth  factors.  The  cohort  of  Quintal  et  al.8
ighlights  the  challenges  of  providing  adequate  nutrition  to
nable growth  in  preterm  infants.  Although  many  units  now
trive to  start  early  feeds,  parenteral  nutrition  (PN)  is  now
ommon place  in  most  NICUs  and  provides  nutrients  whilst
nteral tolerance  is  achieved:  in  this  study,  although  enteral
eeds were  started  soon  after  birth,  most  received  PN  sup-
ort with  an  average  PN  duration  of  12  days.
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Preterm infants  miss  out  on  the  important  phase  of  min-
ral accretion  in  the  third  trimester  and  are  therefore  even
ore vulnerable  to  the  effects  of  inadequate  mineral  pro-
ision in  the  postnatal  period.  Although  PN  solutions  have
mproved dramatically  since  the  first  reports  of  neonatal  use
n  the  late  1960’s,  problems  with  respect  to  mineral  provi-
ion exist  because  calcium  and  phosphate  are  insoluble  in
igh concentrations.  The  increased  availability  of  organic
alts, such  as  sodium  glycerophosphate,  has  improved  sol-
bility (and  therefore  mineral  provision),  and  increased
ntakes of  amino  acids  are  both  likely  to  result  in  higher  lean
ass and  bone  mass  accretion  than  in  the  past,  but  PN  pro-
ision continues  to  lack  a  strong  evidence  base  and  several
oncerns persist.16 In  particular,  aluminium  contamination
emains a  very  common  problem,  and  is  independently  asso-
iated with  reduced  BMC  in  later  childhood.15
Bone  mineral  and  other  growth  deficits  accrued  whilst
nteral nutrition  is  established  often  increase  during  NICU
tay. Mineral  uptake  is  compromised  through  the  low  content
n un-fortified  breast  milk  (especially  phosphate)  and  ineffi-
ient absorption  due  to  an  under-developed  gastrointestinal
ract.6 This  results  in  a  greater  loss  of  long  bone  den-
ity than  observed  in  term  infants  and  further  increases
he risk  of  metabolic  bone  disease.  There  is  compelling
vidence that  optimizing  early  growth  through  nutritional
nterventions generates  positive  and  lasting  effects  on  bone
ineralization,10 which  may  partially  counteract  preterm
one deficits.  A  systematic  review  by  Kusckel  and  Hard-
ng in  2009  showed  that  fortifying  the  nutrition  of  preterm
abies improves  growth  and  bone  mineral  aggregation.17
nternational  guidelines  from  groups  such  as  ESPGHAN
ecommend that  those  receiving  unfortified  breast  milk
hould receive  multivitamin,  iron,  folic  acid,  phosphate,  and
odium supplementation.18
Several  studies  have  emphasized  the  importance  of  early
rowth on  later  bone  health,2 so  it  is  encouraging  to  observe
n this  study  that  the  preterm  infants  demonstrated  sig-
ificant catch-up  growth  with  an  increase  in  mean  weight
-score from  -2.58  at  40  weeks  to  -0.49  at  6  months,  and
n increase  in  mean  length  Z-score  from  -2.22  to  -0.59  at
he 6-month  follow-up.  In  a  study  by  Cooper  et  al,  those
ho were  lightest  at  1  year  of  age  had  the  lowest  BMC.2
n  a  further  study,  weight  gain  during  the  first  two  years  of
ife predicted  BMD  at  age  9-14.19 Fewtrell  et  al.  suggested
hat preterm  infants  with  the  most  substantial  increase  in
eight (length)  between  birth  and  follow-up  showed  the
reatest bone  mass  at  follow-up.12 They  also  demonstrated
hat birth  length  alone  was  a  strong  predictor  of  later  bone
ass, suggesting  that  optimizing  linear  growth  early  may  be
eneficial to  later  bone  health.  However,  the  mean  weight
-score at  term  of  -2.58  in  Quintal  et  al.’s  study8 highlights
he major  challenges  of  promoting  adequate  growth  dur-
ng NICU  stay.  Even  though  the  infants  showed  impressive
atch-up growth  up  to  6  months  of  age,  the  dramatic  fall
n growth  centiles  during  NICU  stay,  followed  by  a period  of
apid growth  acceleration,  represents  a pattern  that  is  very
ifferent to  that  observed  following  normal  pregnancies.
hether this  type  of  growth  trajectory  represents  an  inde-
endent risk  for  later  adverse  metabolic  outcome  requires
urther study,  but  highlights  that  growth,  rather  than  abso-
ute size,  is  the  key  variable  determining  longer-term
ealth.
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The use of DXA scanning as an adjunct to
biochemistry  in the detection of metabolic
bone  disease
Quintal  et  al.  demonstrate  that  DXA  scanning  is  a  reliable
and well-validated  technique  to  estimate  BMC  and  BMD.  It
is well  tolerated  due  to  its  non-invasive  nature  and  short
scan times,  and  the  radiation  levels  involved  are  lower  than
background levels.  The  newer  DXA  machines  with  enhanced
image resolution  enable  accurate  calculation  of  fat  and
lean mass  indices,  although  they  cannot  reliably  determine
adipose tissue  partitioning.  Plain  radiographs  in  preterm
infants on  NICU  frequently  demonstrate  osteopenia,  but
are insensitive  markers  of  BMD.  Biochemical  markers  may
help determine  the  presence  of  metabolic  bone  disease;  for
example, high  levels  of  alkaline  phosphatase  can  be  use-
ful as  a  prompt  to  check  serum  calcium  and  phosphate.20
However,  the  complexity  of  processes  involved  in  metabolic
bone disease  of  prematurity  mean  that  biochemical  mea-
sures are  similarly  insensitive.  The  key  to  management  is  to
focus efforts  that  minimize  its  occurrence  as  much  as  is  fea-
sible in  busy  NICU  settings,  rather  than  perfecting  sensitive
detection methods.  This  can  be  done  by  encouraging  the  use
of  aluminium-free,  high  quality  mineral  supplemented  PN
solutions with  adequate  amounts  of  amino  acids,  combined
with the  early  and  sustained  use  of  breast  milk,  and  supple-
mented by  the  routine  use  of  fortifiers  that  meet  nutrient
requirements.
Epigenetics and bone metabolism
Many  of  the  long-term  effects  on  bone  health  may  be
due to  programming  and  modulated  by  epigenetic  mecha-
nisms --  mitotically-heritable  alterations  in  gene  expression
potential that  are  not  caused  by  changes  in  DNA  sequence.
The classic  examples  are  DNA  methylation  and  histone
acetylation21 and  result  in  differences  in  gene  expression
and transcription,  but  may  also  involve  post-transcriptional
effects on  other  processes  such  as  protein  translation.  Early
life growth  and  nutritional  exposures  appear  to  affect  cellu-
lar memory  and  result  in  variation  in  later  life  phenotypes.
Much of  this  work  is  preliminary,  but  initial  data  suggest  that
epigenetic mechanisms  may  underlie  the  process  of  devel-
opmental plasticity  and  its  effect  on  the  risk  of  osteoporosis.
One of  the  models  that  has  been  postulated  is  the  role
of maternal  vitamin  D  status  and  postnatal  calcium  trans-
fer. Early  work  on  methylation  and  vitamin  D  receptors  and
placental calcium  transporters  suggests  that  epigenetic  reg-
ulation might  explain  how  maternal  vitamin  D  levels  affect
bone mineralization  in  the  neonate.21 Much  of  the  current
research is  in  animal  models,  but  if  the  changes  can  be
replicated in  humans,  epigenetic  or  other  biomarkers  may
provide risk  assessment  tools  to  enable  targeted  interven-
tion to  those  at  greatest  risk  of  osteoporosis.
Future clinical and research prioritiesLongitudinal  studies  with  minimal  attritional  losses,  and
especially those  conducted  within  randomized  controlled
trial settings  are  needed  if  we  are  to  improve  health
1 531
utcomes  of  preterm  infants  across  the  globe.  This  research
eeds to  be  high  quality  and  conducted  in  low-,  middle-,  and
igh-income countries  so  generalizability  can  be  maximized.
isk benefit  ratios  of  medical  interventions  are  sensitive
o the  individual  and  the  healthcare  context.  Neverthe-
ess, the  importance  of  early  bone  and  body  growth  on
he later  development  of  metabolic  diseases  such  as  osteo-
orosis means  that  optimizing  nutrition  both  pre-  and  post-
ospital discharge  must  remain  a  clinical  priority.  Impor-
antly, greater  efforts  must  be  applied  to  support  research
nd quality  improvements  initiatives  within  and  between
ountries --  we  need  to  improve  our  collaborative  working!
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